| Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal S Turajlic, H Xu, K Litchfield, A Rowan, T Chambers, JI Lopez, D Nicol, ... Cell 173 (3), 581-594. e12, 2018 | 712 | 2018 |
| Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal S Turajlic, H Xu, K Litchfield, A Rowan, S Horswell, T Chambers, ... Cell 173 (3), 595-610. e11, 2018 | 546 | 2018 |
| Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal TJ Mitchell, S Turajlic, A Rowan, D Nicol, JHR Farmery, T O’Brien, ... Cell 173 (3), 611-623. e17, 2018 | 466 | 2018 |
| Pervasive chromosomal instability and karyotype order in tumour evolution TBK Watkins, EL Lim, M Petkovic, S Elizalde, NJ Birkbak, GA Wilson, ... Nature 587 (7832), 126-132, 2020 | 275 | 2020 |
| Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, F Byrne, M Cerrone, ... Nature cancer 2 (12), 1305-1320, 2021 | 158 | 2021 |
| Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma L Au, E Hatipoglu, MR de Massy, K Litchfield, G Beattie, A Rowan, ... Cancer cell 39 (11), 1497-1518. e11, 2021 | 152 | 2021 |
| Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2 L Au, A Fendler, STC Shepherd, K Rzeniewicz, M Cerrone, F Byrne, ... Nature Medicine 27 (8), 1362-1366, 2021 | 84 | 2021 |
| Antibodies against endogenous retroviruses promote lung cancer immunotherapy KW Ng, J Boumelha, KSS Enfield, J Almagro, H Cha, O Pich, T Karasaki, ... Nature 616 (7957), 563-573, 2023 | 82 | 2023 |
| Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer A Fendler, STC Shepherd, L Au, M Wu, R Harvey, AM Schmitt, Z Tippu, ... The Lancet 399 (10328), 905-907, 2022 | 74 | 2022 |
| Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, AM Schmitt, Z Tippu, ... Cancer Cell 40 (2), 114-116, 2022 | 66 | 2022 |
| Representative sequencing: unbiased sampling of solid tumor tissue K Litchfield, S Stanislaw, L Spain, LL Gallegos, A Rowan, D Schnidrig, ... Cell reports 31 (5), 2020 | 59 | 2020 |
| Selection of metastasis competent subclones in the tumour interior Y Zhao, X Fu, JI Lopez, A Rowan, L Au, A Fendler, S Hazell, H Xu, ... Nature ecology & evolution 5 (7), 1033-1045, 2021 | 58 | 2021 |
| Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study A Fendler, L Au, STC Shepherd, F Byrne, M Cerrone, LA Boos, ... Nature Cancer 2 (12), 1321-1337, 2021 | 57 | 2021 |
| An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors A O’Reilly, P Hughes, J Mann, Z Lai, JJ Teh, E Mclean, K Edmonds, ... Supportive Care in Cancer 28, 561-570, 2020 | 53 | 2020 |
| Cancer, COVID-19, and antiviral immunity: the CAPTURE study L Au, LA Boos, A Swerdlow, F Byrne, STC Shepherd, A Fendler, S Turajlic Cell 183 (1), 4-10, 2020 | 44 | 2020 |
| Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer AH Ingles Garces, L Au, R Mason, J Thomas, J Larkin Expert Opinion on Investigational Drugs 28 (8), 695-708, 2019 | 39 | 2019 |
| Current and emerging systemic therapies for cutaneous metastatic melanoma R Mason, L Au, A Ingles Garces, J Larkin Expert Opinion on Pharmacotherapy 20 (9), 1135-1152, 2019 | 39 | 2019 |
| Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study X Fu, Y Zhao, JI Lopez, A Rowan, L Au, A Fendler, S Hazell, H Xu, ... Nature ecology & evolution 6 (1), 88-102, 2022 | 34 | 2022 |
| Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis CLC Gudd, L Au, E Triantafyllou, B Shum, T Liu, R Nathwani, N Kumar, ... Journal of hepatology 75 (1), 177-189, 2021 | 32 | 2021 |
| Technical considerations for circulating tumor DNA detection in oncology C Franczak, P Filhine-Tresarrieu, P Gilson, JL Merlin, L Au, A Harlé Expert review of molecular diagnostics 19 (2), 121-135, 2019 | 32 | 2019 |
